Production (Stage)
MedX Health Corp
MDXHF
$0.0008
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 102.26% | -12.86% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 102.26% | -12.86% | |||
| Cost of Revenue | 98.31% | 15.00% | |||
| Gross Profit | 109.20% | -37.81% | |||
| SG&A Expenses | -33.45% | -40.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.61% | -31.06% | |||
| Operating Income | 33.97% | 33.64% | |||
| Income Before Tax | -55.27% | 24.84% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -55.27% | 24.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -55.27% | 24.84% | |||
| EBIT | 33.97% | 33.64% | |||
| EBITDA | 32.54% | 34.18% | |||
| EPS Basic | -52.63% | 26.92% | |||
| Normalized Basic EPS | -50.00% | 25.00% | |||
| EPS Diluted | -52.63% | 26.92% | |||
| Normalized Diluted EPS | -50.00% | 25.00% | |||
| Average Basic Shares Outstanding | -0.21% | 2.01% | |||
| Average Diluted Shares Outstanding | -0.21% | 2.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||